Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
The preventive and promotive approach of our traditional health care systems has played a significant role in modern age today
The acquisition of Aiolos includes AIO-001, a potentially best-in-class, long-acting antithymic stromal lymphopoietin (TSLP) monoclonal antibody
The agreement sets terms under which POC will manufacture the product or receive royalties
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
The restructuring aims to create synergies across the business and strengthen capital structure
Subscribe To Our Newsletter & Stay Updated
